The Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has been rechartered by the Department of Health and Human Services (HHS), according to a notice published under the Federal Advisory Committee Act. The recharter, effective from February 19, 2021, allows the Council to operate until February 19, 2023. The ACBSCT provides expert advice and recommendations to HHS on blood stem cell transplantation programs and related policy matters. Further information, including the Council's charter, can be accessed on their official website or through the FACA database maintained by the General Services Administration.
Simple Explanation
The Advisory Council on Blood Stem Cell Transplantation helps give advice to make sure people who need special blood stem cells for treatment can get them, and they've gotten approval to keep meeting for another two years to continue their work.